Futura Medical PLC increased its retail share offer from £150,000 to £200,000 due to strong investor interest. This retail offer is part of a larger fundraising effort that has conditionally raised about £1.8 million to support the company's strategic review and potential sale or licensing of assets. The funds will extend Futura's cash runway to February 2027, allowing time to explore options including a full company sale or individual asset deals. The company believes its current market value does not reflect the strategic worth of its products like Eroxon and WSD4000.
Pendle became the second-largest DeFi protocol on OKX's XLayer in less than 30 days, reaching $37.5 million in total value locked (TVL). This rapid growth was driven mainly by a single USDG stablecoin market and integration with Aave V3, which allowe...
Zcash (ZEC) has surged past $1,200, reaching a 30-day gain of 134% and a market cap of $20 billion. Garrett Jin, the largest short seller on Hyperliquid, opened a short position at $444 in July and is now facing an unrealized loss of $25.7 million as...
Ethereum co-founder Vitalik Buterin stated that Bitcoin's security challenges can be addressed through standard software and mining pool updates without needing broad social consensus. He dismissed concerns that AI might cause Bitcoin's price to drop...
Dogecoin surged 4.87% to $0.0902 following a short squeeze in derivatives markets that forced bearish traders to cover positions, driving price momentum. Open interest in DOGE futures spiked 8.5% in one hour to $282 million, pushing the coin above it...
Chainlink (LINK) surged 7.06% in 30 minutes, reaching $13.308 and gaining over 10% in 24 hours with trading volume up 25% to $503 million. Derivatives open interest rose 8.26% to nearly $697 million, signaling increased trader activity. Technical ana...
